Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sarepta Therapeutics (SRPT) Q3 2023 Earnings Call Transcript

TheMotleyFool

0 0

Image source: The Motley Fool.

Sarepta Therapeutics (NASDAQ: SRPT)
Q3 2023 Earnings Call
Nov 01, 2023, 4:30 p.m. ET

Operator

Source Fool.com

Sarepta Therapeutics Stock

There is an upward development for Sarepta Therapeutics compared to yesterday, with an increase of €1.95 (1.470%).
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Sarepta Therapeutics stock is not clear.
However, we have a potential of -3.7% for Sarepta Therapeutics as the target price of 130 € is below the current price of 135.0 €.

Like: 0

SRPT

Share